nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—ADORA2A—Parkinson's disease	0.575	0.653	CbGaD
Sildenafil—CYP2E1—Parkinson's disease	0.176	0.2	CbGaD
Sildenafil—CYP2D6—Parkinson's disease	0.129	0.147	CbGaD
Sildenafil—PDE6H—forebrain—Parkinson's disease	0.00277	0.0781	CbGeAlD
Sildenafil—PDE6C—head—Parkinson's disease	0.00269	0.0759	CbGeAlD
Sildenafil—PDE6H—head—Parkinson's disease	0.00159	0.0447	CbGeAlD
Sildenafil—PDE6G—head—Parkinson's disease	0.00153	0.043	CbGeAlD
Sildenafil—PDE6H—nervous system—Parkinson's disease	0.0015	0.0424	CbGeAlD
Sildenafil—PDE6H—central nervous system—Parkinson's disease	0.00145	0.0408	CbGeAlD
Sildenafil—ADORA2A—forebrain—Parkinson's disease	0.00116	0.0326	CbGeAlD
Sildenafil—PDE6H—brain—Parkinson's disease	0.00115	0.0324	CbGeAlD
Sildenafil—PDE5A—forebrain—Parkinson's disease	0.00105	0.0297	CbGeAlD
Sildenafil—ADORA2A—cardiovascular system—Parkinson's disease	0.000978	0.0276	CbGeAlD
Sildenafil—PDE5A—cardiovascular system—Parkinson's disease	0.000891	0.0251	CbGeAlD
Sildenafil—ADORA2A—spinal cord—Parkinson's disease	0.000745	0.021	CbGeAlD
Sildenafil—ABCC5—medulla oblongata—Parkinson's disease	0.000696	0.0196	CbGeAlD
Sildenafil—ABCC4—forebrain—Parkinson's disease	0.000668	0.0188	CbGeAlD
Sildenafil—ADORA2A—head—Parkinson's disease	0.000662	0.0187	CbGeAlD
Sildenafil—ABCC5—midbrain—Parkinson's disease	0.000636	0.0179	CbGeAlD
Sildenafil—ADORA2A—nervous system—Parkinson's disease	0.000628	0.0177	CbGeAlD
Sildenafil—ADORA2A—central nervous system—Parkinson's disease	0.000604	0.0171	CbGeAlD
Sildenafil—PDE5A—head—Parkinson's disease	0.000603	0.017	CbGeAlD
Sildenafil—ADORA2A—cerebellum—Parkinson's disease	0.000591	0.0167	CbGeAlD
Sildenafil—CYP2D6—hindbrain—Parkinson's disease	0.000584	0.0165	CbGeAlD
Sildenafil—ABCC10—medulla oblongata—Parkinson's disease	0.000582	0.0164	CbGeAlD
Sildenafil—PDE5A—nervous system—Parkinson's disease	0.000572	0.0161	CbGeAlD
Sildenafil—PDE5A—central nervous system—Parkinson's disease	0.000551	0.0155	CbGeAlD
Sildenafil—PDE5A—cerebellum—Parkinson's disease	0.000538	0.0152	CbGeAlD
Sildenafil—ABCC10—midbrain—Parkinson's disease	0.000532	0.015	CbGeAlD
Sildenafil—ABCC10—spinal cord—Parkinson's disease	0.000519	0.0146	CbGeAlD
Sildenafil—ABCC5—cerebellum—Parkinson's disease	0.000492	0.0139	CbGeAlD
Sildenafil—ADORA2A—brain—Parkinson's disease	0.00048	0.0135	CbGeAlD
Sildenafil—PDE5A—brain—Parkinson's disease	0.000437	0.0123	CbGeAlD
Sildenafil—ABCC10—cerebellum—Parkinson's disease	0.000411	0.0116	CbGeAlD
Sildenafil—ABCC5—brain—Parkinson's disease	0.0004	0.0113	CbGeAlD
Sildenafil—ABCC4—head—Parkinson's disease	0.000382	0.0108	CbGeAlD
Sildenafil—CYP2C9—cardiovascular system—Parkinson's disease	0.000364	0.0103	CbGeAlD
Sildenafil—ABCC4—nervous system—Parkinson's disease	0.000363	0.0102	CbGeAlD
Sildenafil—ABCC4—central nervous system—Parkinson's disease	0.000349	0.00985	CbGeAlD
Sildenafil—CYP2E1—cardiovascular system—Parkinson's disease	0.000345	0.00973	CbGeAlD
Sildenafil—CYP2D6—brainstem—Parkinson's disease	0.000335	0.00944	CbGeAlD
Sildenafil—ABCC10—brain—Parkinson's disease	0.000334	0.00942	CbGeAlD
Sildenafil—CYP2D6—forebrain—Parkinson's disease	0.000323	0.00912	CbGeAlD
Sildenafil—CYP2E1—medulla oblongata—Parkinson's disease	0.000295	0.00832	CbGeAlD
Sildenafil—ABCC4—brain—Parkinson's disease	0.000277	0.00782	CbGeAlD
Sildenafil—CYP2E1—spinal cord—Parkinson's disease	0.000263	0.00742	CbGeAlD
Sildenafil—CYP1A1—head—Parkinson's disease	0.000256	0.00723	CbGeAlD
Sildenafil—CYP1A1—nervous system—Parkinson's disease	0.000243	0.00685	CbGeAlD
Sildenafil—CYP1A1—central nervous system—Parkinson's disease	0.000234	0.0066	CbGeAlD
Sildenafil—CYP2E1—head—Parkinson's disease	0.000234	0.00659	CbGeAlD
Sildenafil—CYP2E1—nervous system—Parkinson's disease	0.000222	0.00625	CbGeAlD
Sildenafil—CYP2E1—central nervous system—Parkinson's disease	0.000213	0.00602	CbGeAlD
Sildenafil—CYP2E1—cerebellum—Parkinson's disease	0.000208	0.00588	CbGeAlD
Sildenafil—CYP1A1—brain—Parkinson's disease	0.000186	0.00524	CbGeAlD
Sildenafil—CYP2D6—head—Parkinson's disease	0.000185	0.00522	CbGeAlD
Sildenafil—CYP3A4—nervous system—Parkinson's disease	0.000178	0.00503	CbGeAlD
Sildenafil—CYP2D6—nervous system—Parkinson's disease	0.000175	0.00495	CbGeAlD
Sildenafil—CYP3A4—central nervous system—Parkinson's disease	0.000172	0.00484	CbGeAlD
Sildenafil—CYP2E1—brain—Parkinson's disease	0.000169	0.00478	CbGeAlD
Sildenafil—CYP2D6—central nervous system—Parkinson's disease	0.000169	0.00476	CbGeAlD
Sildenafil—CYP2D6—cerebellum—Parkinson's disease	0.000165	0.00466	CbGeAlD
Sildenafil—CYP2D6—brain—Parkinson's disease	0.000134	0.00378	CbGeAlD
Sildenafil—CYP3A7—Metabolism—GSTA4—Parkinson's disease	2.71e-05	0.000319	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.7e-05	0.000318	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—COMT—Parkinson's disease	2.7e-05	0.000318	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—HTR2A—Parkinson's disease	2.69e-05	0.000317	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—INS—Parkinson's disease	2.69e-05	0.000316	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—GSTP1—Parkinson's disease	2.68e-05	0.000316	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—MAOA—Parkinson's disease	2.68e-05	0.000315	CbGpPWpGaD
Sildenafil—CYP3A4—Biological oxidations—COMT—Parkinson's disease	2.67e-05	0.000315	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—FBP1—Parkinson's disease	2.67e-05	0.000314	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GBA—Parkinson's disease	2.67e-05	0.000314	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—DBH—Parkinson's disease	2.67e-05	0.000314	CbGpPWpGaD
Sildenafil—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	2.66e-05	0.000313	CbGpPWpGaD
Sildenafil—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	2.65e-05	0.000312	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ND3—Parkinson's disease	2.65e-05	0.000312	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—MCCC1—Parkinson's disease	2.65e-05	0.000312	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—HMOX1—Parkinson's disease	2.65e-05	0.000312	CbGpPWpGaD
Sildenafil—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	2.63e-05	0.00031	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—MCCC1—Parkinson's disease	2.63e-05	0.000309	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ND3—Parkinson's disease	2.63e-05	0.000309	CbGpPWpGaD
Sildenafil—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	2.62e-05	0.000309	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MTHFR—Parkinson's disease	2.6e-05	0.000307	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—INSR—Parkinson's disease	2.59e-05	0.000305	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	2.57e-05	0.000302	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—ABCB1—Parkinson's disease	2.54e-05	0.000299	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—OMD—Parkinson's disease	2.49e-05	0.000293	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—TALDO1—Parkinson's disease	2.49e-05	0.000293	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—TALDO1—Parkinson's disease	2.47e-05	0.000291	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—OMD—Parkinson's disease	2.47e-05	0.000291	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—GSTM1—Parkinson's disease	2.47e-05	0.000291	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GCH1—Parkinson's disease	2.45e-05	0.000288	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—FGB—Parkinson's disease	2.45e-05	0.000288	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—HTR2A—Parkinson's disease	2.44e-05	0.000288	CbGpPWpGaD
Sildenafil—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	2.44e-05	0.000288	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PLA2G6—Parkinson's disease	2.44e-05	0.000287	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HTR1A—Parkinson's disease	2.44e-05	0.000287	CbGpPWpGaD
Sildenafil—ABCC5—Disease—APOE—Parkinson's disease	2.42e-05	0.000285	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—MAOB—Parkinson's disease	2.41e-05	0.000284	CbGpPWpGaD
Sildenafil—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	2.41e-05	0.000284	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TAC1—Parkinson's disease	2.4e-05	0.000283	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—GPX1—Parkinson's disease	2.36e-05	0.000278	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	2.36e-05	0.000278	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—DRD1—Parkinson's disease	2.35e-05	0.000277	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	2.34e-05	0.000276	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—IL6—Parkinson's disease	2.33e-05	0.000275	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—DRD3—Parkinson's disease	2.28e-05	0.000268	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GCH1—Parkinson's disease	2.25e-05	0.000265	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GCH1—Parkinson's disease	2.23e-05	0.000263	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.21e-05	0.00026	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—FBP1—Parkinson's disease	2.18e-05	0.000257	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—DBH—Parkinson's disease	2.18e-05	0.000257	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GBA—Parkinson's disease	2.18e-05	0.000257	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—MTHFR—Parkinson's disease	2.18e-05	0.000257	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ADRBK1—Parkinson's disease	2.13e-05	0.000251	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—DDC—Parkinson's disease	2.08e-05	0.000245	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—DDC—Parkinson's disease	2.07e-05	0.000244	CbGpPWpGaD
Sildenafil—ABCC5—Disease—INS—Parkinson's disease	2.07e-05	0.000244	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—DRD2—Parkinson's disease	2.06e-05	0.000243	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HTR7—Parkinson's disease	2.06e-05	0.000243	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—APOE—Parkinson's disease	2.03e-05	0.000239	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.01e-05	0.000237	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—DBH—Parkinson's disease	2.01e-05	0.000236	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—FBP1—Parkinson's disease	2.01e-05	0.000236	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GBA—Parkinson's disease	2.01e-05	0.000236	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CASP3—Parkinson's disease	2e-05	0.000235	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—FBP1—Parkinson's disease	1.99e-05	0.000234	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GBA—Parkinson's disease	1.99e-05	0.000234	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—DBH—Parkinson's disease	1.99e-05	0.000234	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GSTA4—Parkinson's disease	1.96e-05	0.000231	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—DDC—Parkinson's disease	1.96e-05	0.000231	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GSTA4—Parkinson's disease	1.96e-05	0.00023	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GSTA4—Parkinson's disease	1.85e-05	0.000218	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—MAPK8—Parkinson's disease	1.84e-05	0.000216	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.83e-05	0.000215	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CYP2D6—Parkinson's disease	1.79e-05	0.000211	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PLA2G6—Parkinson's disease	1.77e-05	0.000208	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PLA2G6—Parkinson's disease	1.76e-05	0.000208	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CTGF—Parkinson's disease	1.76e-05	0.000207	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—MAOB—Parkinson's disease	1.75e-05	0.000206	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—MAOB—Parkinson's disease	1.74e-05	0.000205	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—INS—Parkinson's disease	1.73e-05	0.000204	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—MCCC1—Parkinson's disease	1.73e-05	0.000204	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ND3—Parkinson's disease	1.73e-05	0.000204	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IGF2—Parkinson's disease	1.73e-05	0.000203	CbGpPWpGaD
Sildenafil—PDE6G—Disease—IL6—Parkinson's disease	1.68e-05	0.000197	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IGF1R—Parkinson's disease	1.67e-05	0.000197	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PLA2G6—Parkinson's disease	1.66e-05	0.000196	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—EDN1—Parkinson's disease	1.65e-05	0.000194	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—MAOB—Parkinson's disease	1.65e-05	0.000194	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CYP2E1—Parkinson's disease	1.64e-05	0.000193	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—TALDO1—Parkinson's disease	1.63e-05	0.000192	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—OMD—Parkinson's disease	1.63e-05	0.000192	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—NQO1—Parkinson's disease	1.62e-05	0.000191	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—DDC—Parkinson's disease	1.6e-05	0.000189	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—TH—Parkinson's disease	1.6e-05	0.000188	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.57e-05	0.000185	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	1.54e-05	0.000182	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CYCS—Parkinson's disease	1.53e-05	0.000181	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NGF—Parkinson's disease	1.52e-05	0.000179	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GSTA4—Parkinson's disease	1.51e-05	0.000178	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.49e-05	0.000176	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—DDC—Parkinson's disease	1.47e-05	0.000174	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GCH1—Parkinson's disease	1.47e-05	0.000173	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—DDC—Parkinson's disease	1.46e-05	0.000172	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HTR2A—Parkinson's disease	1.44e-05	0.00017	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTA4—Parkinson's disease	1.39e-05	0.000164	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTA4—Parkinson's disease	1.38e-05	0.000162	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	1.36e-05	0.00016	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.36e-05	0.00016	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—COMT—Parkinson's disease	1.36e-05	0.00016	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GSTP1—Parkinson's disease	1.35e-05	0.000159	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—MAOA—Parkinson's disease	1.35e-05	0.000159	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—MAOB—Parkinson's disease	1.35e-05	0.000159	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—APOE—Parkinson's disease	1.34e-05	0.000158	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—HMOX1—Parkinson's disease	1.33e-05	0.000157	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.31e-05	0.000155	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—DBH—Parkinson's disease	1.31e-05	0.000155	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GBA—Parkinson's disease	1.31e-05	0.000155	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP2D6—Parkinson's disease	1.3e-05	0.000153	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP2D6—Parkinson's disease	1.3e-05	0.000153	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.28e-05	0.000151	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—ABCB1—Parkinson's disease	1.28e-05	0.000151	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CTGF—Parkinson's disease	1.28e-05	0.00015	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CTGF—Parkinson's disease	1.27e-05	0.00015	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	1.25e-05	0.000148	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GSTM1—Parkinson's disease	1.24e-05	0.000146	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	1.24e-05	0.000146	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.24e-05	0.000146	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—MAOB—Parkinson's disease	1.23e-05	0.000145	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CYP2D6—Parkinson's disease	1.22e-05	0.000144	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CTGF—Parkinson's disease	1.2e-05	0.000142	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GPX1—Parkinson's disease	1.19e-05	0.00014	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP2E1—Parkinson's disease	1.19e-05	0.00014	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—NQO1—Parkinson's disease	1.17e-05	0.000138	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—IL6—Parkinson's disease	1.17e-05	0.000138	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—NQO1—Parkinson's disease	1.17e-05	0.000138	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.17e-05	0.000138	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—TH—Parkinson's disease	1.16e-05	0.000136	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—TH—Parkinson's disease	1.16e-05	0.000136	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—INS—Parkinson's disease	1.15e-05	0.000135	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CYP2E1—Parkinson's disease	1.12e-05	0.000132	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYCS—Parkinson's disease	1.11e-05	0.000131	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYCS—Parkinson's disease	1.11e-05	0.000131	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—NQO1—Parkinson's disease	1.11e-05	0.00013	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—MTHFR—Parkinson's disease	1.1e-05	0.000129	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—TH—Parkinson's disease	1.09e-05	0.000129	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CYCS—Parkinson's disease	1.05e-05	0.000123	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—APOE—Parkinson's disease	1.02e-05	0.00012	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	1e-05	0.000118	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—COMT—Parkinson's disease	9.84e-06	0.000116	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CTGF—Parkinson's disease	9.84e-06	0.000116	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—COMT—Parkinson's disease	9.82e-06	0.000116	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GSTP1—Parkinson's disease	9.8e-06	0.000115	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GSTP1—Parkinson's disease	9.78e-06	0.000115	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—MAOA—Parkinson's disease	9.78e-06	0.000115	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—MAOA—Parkinson's disease	9.76e-06	0.000115	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—HMOX1—Parkinson's disease	9.66e-06	0.000114	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—HMOX1—Parkinson's disease	9.64e-06	0.000114	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—DDC—Parkinson's disease	9.63e-06	0.000113	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—COMT—Parkinson's disease	9.28e-06	0.000109	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ABCB1—Parkinson's disease	9.27e-06	0.000109	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ABCB1—Parkinson's disease	9.26e-06	0.000109	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GSTP1—Parkinson's disease	9.24e-06	0.000109	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—MAOA—Parkinson's disease	9.22e-06	0.000109	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	9.17e-06	0.000108	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	9.14e-06	0.000108	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—HMOX1—Parkinson's disease	9.11e-06	0.000107	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTA4—Parkinson's disease	9.1e-06	0.000107	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—NQO1—Parkinson's disease	9.06e-06	0.000107	CbGpPWpGaD
Sildenafil—ABCC5—Disease—IL6—Parkinson's disease	9.05e-06	0.000107	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CTGF—Parkinson's disease	9.05e-06	0.000107	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GSTM1—Parkinson's disease	9e-06	0.000106	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GSTM1—Parkinson's disease	8.99e-06	0.000106	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CTGF—Parkinson's disease	8.97e-06	0.000106	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—TH—Parkinson's disease	8.93e-06	0.000105	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ABCB1—Parkinson's disease	8.74e-06	0.000103	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—INS—Parkinson's disease	8.74e-06	0.000103	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GPX1—Parkinson's disease	8.62e-06	0.000102	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GPX1—Parkinson's disease	8.6e-06	0.000101	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYCS—Parkinson's disease	8.58e-06	0.000101	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CASP3—Parkinson's disease	8.53e-06	0.000101	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GSTM1—Parkinson's disease	8.49e-06	0.0001	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—IL6—Parkinson's disease	8.48e-06	9.99e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	8.43e-06	9.93e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	8.36e-06	9.84e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—NQO1—Parkinson's disease	8.34e-06	9.82e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—NQO1—Parkinson's disease	8.26e-06	9.73e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—TH—Parkinson's disease	8.22e-06	9.68e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	8.19e-06	9.65e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—TH—Parkinson's disease	8.14e-06	9.59e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GPX1—Parkinson's disease	8.13e-06	9.58e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—MAOB—Parkinson's disease	8.11e-06	9.55e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—MTHFR—Parkinson's disease	7.96e-06	9.37e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—MTHFR—Parkinson's disease	7.94e-06	9.35e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYCS—Parkinson's disease	7.89e-06	9.29e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MAPK8—Parkinson's disease	7.84e-06	9.24e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYCS—Parkinson's disease	7.82e-06	9.21e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—COMT—Parkinson's disease	7.6e-06	8.95e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GSTP1—Parkinson's disease	7.56e-06	8.9e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—MAOA—Parkinson's disease	7.54e-06	8.88e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—MTHFR—Parkinson's disease	7.5e-06	8.84e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—HMOX1—Parkinson's disease	7.46e-06	8.78e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—APOE—Parkinson's disease	7.41e-06	8.73e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—APOE—Parkinson's disease	7.39e-06	8.71e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ABCB1—Parkinson's disease	7.16e-06	8.43e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—COMT—Parkinson's disease	6.99e-06	8.23e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—APOE—Parkinson's disease	6.98e-06	8.23e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTP1—Parkinson's disease	6.95e-06	8.19e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GSTM1—Parkinson's disease	6.95e-06	8.18e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—MAOA—Parkinson's disease	6.94e-06	8.17e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—COMT—Parkinson's disease	6.93e-06	8.16e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTP1—Parkinson's disease	6.89e-06	8.12e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—MAOA—Parkinson's disease	6.88e-06	8.1e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—HMOX1—Parkinson's disease	6.86e-06	8.08e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—HMOX1—Parkinson's disease	6.8e-06	8.01e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GPX1—Parkinson's disease	6.65e-06	7.84e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ABCB1—Parkinson's disease	6.58e-06	7.75e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ABCB1—Parkinson's disease	6.52e-06	7.69e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTM1—Parkinson's disease	6.39e-06	7.53e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTM1—Parkinson's disease	6.33e-06	7.46e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—INS—Parkinson's disease	6.33e-06	7.45e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—INS—Parkinson's disease	6.32e-06	7.44e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—MTHFR—Parkinson's disease	6.14e-06	7.23e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GPX1—Parkinson's disease	6.12e-06	7.21e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GPX1—Parkinson's disease	6.07e-06	7.14e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	6.03e-06	7.1e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—INS—Parkinson's disease	5.97e-06	7.03e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CTGF—Parkinson's disease	5.92e-06	6.97e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—APOE—Parkinson's disease	5.72e-06	6.73e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—MTHFR—Parkinson's disease	5.65e-06	6.65e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—MTHFR—Parkinson's disease	5.6e-06	6.59e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	5.51e-06	6.49e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NQO1—Parkinson's disease	5.45e-06	6.42e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—TH—Parkinson's disease	5.37e-06	6.33e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—APOE—Parkinson's disease	5.26e-06	6.19e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—APOE—Parkinson's disease	5.21e-06	6.14e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYCS—Parkinson's disease	5.16e-06	6.07e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IL6—Parkinson's disease	5.01e-06	5.9e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—INS—Parkinson's disease	4.88e-06	5.75e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—COMT—Parkinson's disease	4.57e-06	5.38e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTP1—Parkinson's disease	4.55e-06	5.35e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—MAOA—Parkinson's disease	4.54e-06	5.34e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—INS—Parkinson's disease	4.49e-06	5.29e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—HMOX1—Parkinson's disease	4.48e-06	5.28e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—INS—Parkinson's disease	4.45e-06	5.24e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ABCB1—Parkinson's disease	4.3e-06	5.07e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTM1—Parkinson's disease	4.18e-06	4.92e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GPX1—Parkinson's disease	4e-06	4.71e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—MTHFR—Parkinson's disease	3.69e-06	4.35e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—APOE—Parkinson's disease	3.44e-06	4.05e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—INS—Parkinson's disease	2.94e-06	3.46e-05	CbGpPWpGaD
